Recently Guangzhou Hybribio Medical Laboratory Ltd. has officially reached a cooperation agreement with the European molecular genetic diagnosis quality Alliance (EMQN). The two sides will work together to maintain and improve Chinese molecular clinical diagnosis standard,  devote to make molecular diagnosis and treatment more precisely through training and coordination.

As a domestic molecular diagnostic reagents manufacturer and diagnostic service provider, Hybribio has established a completed operating chain of R&D, manufacturing, sales and marketing and after-sales technical services. Through the Hybribio network, EMQN will better support the laboratories participating in the plan and thereby provide high-quality and timely external assessment services. In the future, Hybribio will support the registration, charge, transportation and other services of all EMQN external quality assessment plans. Guangzhou Hybribio Medical Laboratory Ltd., as a holding subsidiary of Hybribio, its mission is to become a reliable partner for doctors and a reliable molecular diagnostic expert for patients.

About EMQN

The European Molecular Genetics quality network (EMQN) , founded in 1998, is a non-profit organization. It has long been committed to help participated genetics clinical lab to improve clinical molecular diagnosis and testing standards by providing external quality assessment service. EMQN aims to improve the quality of genetic testing by establishing, coordinating, and spreading the best practices. It has served more than 1600 laboratories in 79 countries.